Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Vascular by Year
Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Constant Currency Sales Growth YoY (%) (%)
Stryker Vascular: 50.0% in FY2025, up 41.8 pts from a year earlier.
Latest, FY2025
50.0%
Period ended Dec 31, 2025
Change on a year earlier
+41.8 pts
8.2% in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Where the FY2025 figure comes from
Reported in Stryker Form 8-K Supplemental Sales Schedules.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Vascular (Neurovascular Ischemic/Hemorrhagic Stroke & Inari Peripheral Vascular) — Worldwide Constant Currency Sales Growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 50.0% | +41.8 pts | 0000310764-26-000006|sykex991earningsq42025.htm ↗ |
| FY2024 | Dec 31, 2024 | 8.2% | +4.2 pts | 0000310764-25-000005|sykex991earningsq42024.htm ↗ |
| FY2023 | Dec 31, 2023 | 4.0% | -3.2 pts | 0000310764-24-000005|sykex991earningsq42023.htm ↗ |
| FY2022 | Dec 31, 2022 | 7.2% | -12.3 pts | 0000310764-23-000005|sykex991earningsq42022.htm ↗ |
| FY2021 | Dec 31, 2021 | 19.5% | – | 0000310764-22-000008|sykex991earningsq42021.htm ↗ |
Cite this data
StockData. (2026). Stryker Vascular (%), annual FY2021–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/fran-vasc-ww-cc
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.